Mercer Global Advisors
ARRY

Mercer Global Advisors’s Array Biopharma Inc ARRY Stock Holding History

Mercer Global Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,192
Closed -$519K – 1233
2019
Q2 		$519K Buy
11,192
+661
+6% +$18.6K 0.01% 666
2019
Q1 		$257K Buy
+10,531
New +$219K 0.01% 882

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Mercer Global Advisors's ARRY Position: Q3 2019 in Review

Mercer Global Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 11,192 shares — an estimated $519K sold.

Mercer Global Advisors first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $519K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Mercer Global Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Mercer Global Advisors sold 11,192 Array Biopharma Inc shares in Q3 2019, an estimated $519K.
  • Mercer Global Advisors first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
  • Mercer Global Advisors's Array Biopharma Inc position peaked at $519K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Mercer Global Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.